A mass spectrometry-based approach for studying kinase activity — ASN Events
  1. Schedule
  2. Concurrent Mini-Symposium 2
  3. A mass spectrometry-based approach for studying kinase activity

A mass spectrometry-based approach for studying kinase activity (#33)

Laura F Dagley 1 2 , Tatiana B Kolesnik 1 2 , Ee Shan Pang 1 2 , Phillip P Sharp 1 2 , Edmond M Linossi 1 2 , Gabrielle L Goldberg 1 2 , James M Murphy 1 2 , Andrew I Webb 1 2 , Christopher J Burns 1 2 , Ian P Wicks 1 2 , Nicos A Nicola 1 2 , Jeffrey J Babon 1 2 , Isabelle S Lucet 1 2 , Sandra E Nicholson 1 2
  1. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
  2. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia

Protein kinases play a key role in numerous cell signaling pathways. They have emerged as an important class of enzymes since aberrant kinase activity is associated with human cancers and inflammatory disorders. Whilst the human kinome is comprised of over 500 members, only a fraction have been exploited as drug targets for therapeutic interventions. Thus, many members of the kinase superfamily and their role in human diseases remain poorly understood. This can be attributed to the fact they are in low cellular abundance in complex protein samples and their detection is reliant on the quality of available phosphoantibodies. In recent years, efforts have been made to develop immobilized small-molecule kinase inhibitors as kinase-capturing reagents. When coupled with highly sensitive mass spectrometry analysis, this kinase enrichment step allows for the comprehensive scanning of the kinome and the identification of dysregulated kinase signaling networks in disease states1.

In this study, we have used two kinase-capturing reagents to profile the kinome from various cellular sources including HEK293Ts, human G-CSF-mobilised neutrophils and murine bone marrow-derived macrophages (BMDMs). Kinome enrichment was achieved using CTx-0294885 resin (KiNET-1 beads, SYNkinase) and a pan-JAK1/2 inhibitor CYT387 (Cytopia/Gilead) coupled to NHS-sepharose beads. In this way we identified a number of novel kinases within specific cell types, some of which may play important roles in the context of disease. This kinome profiling strategy was performed alongside a phosphopeptide enrichment strategy for quantitative mass spectrometry analysis. Using this approach we identified a number of novel phosphopeptide sites within clinically-relevant kinases including the JAK protein tyrosine kinases. We identified 40 phosphorylation sites in murine JAK2 (23 novel and 17 known sites), whilst 43 phosphorylation sites were identified in murine JAK1 (32 novel and 11 known sites). Mutational studies are currently underway to screen a selection of evolutionarily-conserved candidate phosphorylation sites for functional relevance.

The authors would like to acknowledge Leanne Daly from Synkinase for supplying the KiNET-1 beads used in this study.

  1. Zhang, L., et al. (2013). "Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling." J Proteome Res 12(7): 3104-3116.